Union Therapeutics begins phase IIb trial of eczema tablet
![Denmark-based Union Therapeutics has yet to bring a product to market, but has several late-stage trials planned for lead-candidate orismilast | Photo: Union Therapeutics / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14283090.ece/ALTERNATES/schema-16_9/doc7m5r9z7qotisb9gbaew.jpg)
Union Therapeutics has enrolled its first patient in a phase IIb trial and aims to find a total of 210 participants, the firm reports in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
FDA expands Dupixent indication, EU application to follow
For subscribers